Deploying artificial intelligence algorithms and digital cognitive testing platforms is accelerating screening workflows within the Alzheimer’s Disease Diagnostic Market. Smartphone and tablet-based digital cognitive apps evaluate subtle changes in speech patterns, eye tracking, and spatial memory, identifying early mild cognitive impairment (MCI) in home or primary care environments....